We are live on ! Find out more
ACM

Athyrium Capital Management Portfolio holdings

AUM $8.69M
1-Year Est. Return 34.58%
This Fund
S&P 500
This Quarter Est. Return
+45.44%
1 Year Est. Return
-34.58%
3 Year Est. Return
-25.1%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$279M
AUM Growth
+$41.2M
Cap. Flow
-$136M
Cap. Flow %
-48.73%
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
–
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CMAX
CareMax, Inc. Class A Common Stock
CMAX
+$16.3M
2
SCTL
Societal CDMO, Inc. Common Stock
SCTL
+$3.28M

Sector Composition

Rank Sector Weight
1 Healthcare 55.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMYT
1
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$129M 46.27%
8,857,268
– –
RVLP
2
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$16.6M 5.96%
14,600,444
– –
PBYI icon
3
Puma Biotechnology
PBYI
$398M
$5.54M 1.98%
1,792,114
– –
BIOR
4
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$4.69M 1.68%
169,448
– –
SCTL
5
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
– –
-2,202,420
Closed -$3.28M
CMAX
6
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
– –
-148,907
Closed -$16.3M

Similar funds

BGC
Birch Grove Capital New York $9.51M AUM 0.22% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
JDR
Jay D. Rosenbaum $6.69M AUM 4.68% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
KIM
Kaizen Investment Management Singapore $6.23M AUM
RJTCONH
Raymond James Trust Company of New Hampshire Portsmouth, New Hampshire $12.1M AUM 28.84% 1-Year Est. Return
HSC
Harbor Spring Capital New York $12.3M AUM
HVM
Harvest Volatility Management Norwalk, Connecticut $4.39M AUM 13.08% 1-Year Est. Return

Athyrium Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Athyrium Capital Management held 10 positions worth $279M, up 17% from $238M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Athyrium Capital Management withdrew a net $136M in Q1 2023, closing 2 positions. Its most notable exit was CareMax, Inc. Class A Common Stock, an estimated $16.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, up from 48% a quarter earlier.

  • Athyrium Capital Management fully exited CareMax, Inc. Class A Common Stock in Q1 2023, selling an estimated $16.3M.
  • Athyrium Capital Management's ten largest holdings make up 100% of its $279M portfolio in Q1 2023.
  • Athyrium Capital Management opened 0 new positions and closed 2 in Q1 2023.
  • Athyrium Capital Management's portfolio value rose 17% quarter-over-quarter to $279M.

Based on Athyrium Capital Management's 13F filing for Q1 2023, filed 15 May 2023.